Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeAmgen Inc

      Amgen Inc

      Bristol-Myers Sees Price Target Cut
      Investing News

      Bristol-Myers Sees Price Target Cut

      April 26, 2025
      Bristol Myers Stock Decline: A Buying Opportunity
      Investing News

      Bristol Myers Stock Decline: A Buying Opportunity

      February 6, 2025
      Amgen’s Rocatinlimab Shows Promising Results
      Market News

      Amgen’s Rocatinlimab Shows Promising Results

      September 27, 2024
      Amgen Skyrockets as CEO Touts MariTide Obesity Drug Progress
      Investing News

      Amgen Skyrockets as CEO Touts MariTide Obesity Drug Progress

      May 3, 2024
      Should You Buy Amgen Stock for Its 3% Yield?
      Investing News

      Should You Buy Amgen Stock for Its 3% Yield?

      April 29, 2024
      Amgen Reduces Its Sales Forecast After Announcing Plans To Acquire ChemoCentryx
      Investing News

      Amgen Reduces Its Sales Forecast After Announcing Plans To Acquire ChemoCentryx

      August 5, 2022

       

      LATEST NEWS

      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025